Loading data
CDTGNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 18.23 m USD | 29.77 m USD | 34.21 m USD | 28.85 m USD | 23.56 m USD |
| Cost of revenue | 10.67 m USD | 18.52 m USD | 22.83 m USD | 18.6 m USD | 15.06 m USD |
| Gross profit | 7.56 m USD | 11.25 m USD | 11.38 m USD | 10.25 m USD | 8.49 m USD |
| Research and development expense | 47.6 k USD | 61.79 k USD | 80.95 k USD | 112.67 k USD | 136.69 k USD |
| Operating profit | -11.65 m USD | 2 m USD | 8.61 m USD | 6.35 m USD | 7.65 m USD |
| Interest expense | 91.45 k USD | 136.76 k USD | 106.13 k USD | 64.66 k USD | 68.66 k USD |
| Profit before tax | -11.63 m USD | 1.87 m USD | 8.43 m USD | 6.4 m USD | 7.79 m USD |
| Income tax expense | -1.27 m USD | 462.04 k USD | 1.4 m USD | 1.15 m USD | 1.21 m USD |
| Net income (reported basis) | -10.2 m USD | 1.45 m USD | 7.42 m USD | 5.78 m USD | 6.78 m USD |
| Basic earnings per share | -0.84 USD/share | 0.14 USD/share | 0.81 USD/share | 0.63 USD/share | 0.74 USD/share |
| Diluted earnings per share | -0.84 USD/share | 0.14 USD/share | 0.81 USD/share | 0.63 USD/share | 0.74 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.